Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Parkinson's disease includes neuropsychiatric manifestations, such as depression, anxiety, apathy, psychosis, and impulse control disorders, which often are unreported by patients and caregivers or undetected by doctors. Given their substantial impact on patients and caregivers as well as the existence of effective therapies for some of these disorders, screening for neuropsychiatric symptoms is important. Instruments for screening have a particular methodology for validation, and their performance is expressed in terms of accuracy compared with formal diagnostic criteria. The present study reviews the attributes of the screening instruments applied for detection of the aforementioned major neuropsychiatric symptoms in Parkinson's disease. A quasi‐systematic review (including predefined selection criteria, but not evaluating the quality of the reviewed studies) was carried out on the basis of previous systematic reviews (commissioned by the American Academy of Neurology and the Movement Disorder Society) and made current by conducting a literature search (2005–2014). For depression, 11 scales and questionnaires were shown to be valid for Parkinson's disease screening. The recently developed Parkinson Anxiety Scale and the Geriatric Anxiety Inventory demonstrate satisfactory properties as screening instruments for anxiety, and the Lille Apathy Rating Scale for detection of apathy. No scale adequately screens for psychosis, so a specific psychosis instrument should be developed. The Questionnaire for Impulsive‐Compulsive Disorders in Parkinson's Disease (Questionnaire and Rating Scale) are valid for comprehensive screening of impulse control disorders, and the Parkinson's Disease–Sexual Addiction Screening Test for hypersexuality specifically. © 2015 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Instrument For Anxiety Disorders
Zung, W. W. K. (1971) · Psychosomatics · doi:10.1016/s0033-3182(71)71479-0 · Cited by 4,578
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1184 · Cited by 2,948
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Empirical evidence of design-related bias in studies of diagnostic tests.
Lijmer, J. G. (1999) · JAMA · doi:10.1001/jama.282.11.1061 · Cited by 1,861 · cited 1×
“Overestimation of test performance, for example, is typically observed in the following scenarios: (1) case-control studies, (2) when different reference tests are applied to subjects who are positive and negative for the assessed test, (3) when the reference test is not applied in a blind manner, or (4) when there is…”
BackgroundMeasurement of compulsive hoarding: saving inventory-revised
Frost, R. O., Steketee, G., & Grisham, J. (2004) · Behaviour Research and Therapy · doi:10.1016/j.brat.2003.07.006 · Cited by 803
Non-recognition of depression and other non-motor symptoms in Parkinson's disease
Shulman, L. M., Taback, R. L., Rabinstein, A. A., & Weiner, W. J. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00015-3 · Cited by 695
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
Weintraub, D., Hoops, S., Shea, J. A., Lyons, K. E., Pahwa, R., Driver‐Dunckley, E. D., Adler, C. H., Potenza, M. N., Miyasaki, J., Siderowf, A. D., et al. (2009) · Movement Disorders · doi:10.1002/mds.22571 · Cited by 528
Self-citationMedication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease
Voon, V., & Fox, S. H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.8.1089 · Cited by 397
Apathy in Parkinson's disease: A systematic review and meta‐analysis
den Brok, M. G. H. E., van Dalen, J. W., van Gool, W. A., Moll van Charante, E. P., de Bie, R. M. A., & Richard, E. (2015) · Movement Disorders · doi:10.1002/mds.26208 · Cited by 376
The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale
Leentjens, A. F. G., Dujardin, K., Pontone, G. M., Starkstein, S. E., Weintraub, D., & Martinez‐Martin, P. (2014) · Movement Disorders · doi:10.1002/mds.25919 · Cited by 270 · cited 1×
“The end result, the Parkinson Anxiety Scale (PAS), includes subscales for persistent anxiety, episodic anxiety, and avoidance behavior and exists in both patientand clinician-rated versions.(52) Although not specifically designed for screening or diagnosis, its properties in this regard were tested against the gold st…”
MethodSelf-citation
Cited by
The neuropsychiatry of Parkinson's disease: advances and challenges
Weintraub, D., Aarsland, D., Chaudhuri, K. R., Dobkin, R. D., Leentjens, A. F., Rodriguez-Violante, M., & Schrag, A. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00330-6 · Cited by 450
Self-citationNeuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
Balestrino, R., & Martinez-Martin, P. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.060 · Cited by 135
Nakum, S., & Cavanna, A. E. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.017 · Cited by 70
Zhang, P., Huang, P., Li, Y., Du, J., Luo, N., He, Y., Liu, J., He, G., Cui, S., Zhang, W., et al. (2024) · Aging and disease · doi:10.14336/ad.2023.0518 · Cited by 30
Metadata
- Authors
- Martinez‐Martin, P., Leentjens, A. F. G., de Pedro‐Cuesta, J., Chaudhuri, K. R., Schrag, A. E., & Weintraub, D.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2015-12-22
- Volume
- 31
- Issue
- 3
- Pages
- 270-279
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2212500737
- Cited by
- 72
- References
- 12
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.